SCHEMBL2492199

SCHEMBL2492199

Clc1cccc(-c2c[c]no2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 1/20 0.42
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
TP53 P04637 2/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NOTUM Q6P988 4/20 0.41
SOS1 Q07889 1/20 0.41
THRB P10828 1/20 0.40
GABRP O00591 2/20 0.40
GABRD O14764 2/20 0.40
GABRA1 P14867 2/20 0.40
GABRB1 P18505 2/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRA5 P31644 2/20 0.40
GABRA3 P34903 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28585173 0.79 NR4A1 (0.41) TP53NOTUMGABRPGABRDGABRA1
SCHEMBL1546713 0.77 NOTUM (0.48) TDO2NPC1RAB9ANOTUM
SCHEMBL70373 0.77 RAB9A (0.42) NPC1RAB9ATSHRSMN1; SMN2NOTUM
SCHEMBL5965311 0.76 AHR (0.46) NPC1RAB9ASMN1; SMN2NOTUM
SCHEMBL3677936 0.75 NOTUM (0.45) NPC1RAB9ANOTUMMAPK1
SCHEMBL5965271 0.73 RAB9A (0.39) NPC1RAB9ATSHRNFKB1NFKB2
SCHEMBL28718439 0.72 KMO (0.36) NOTUMPTGS1PTGS2
SCHEMBL2337861 0.70 SOS1 (0.42) TDO2NPC1RAB9ATP53TSHR
SCHEMBL9188823 0.70 NOTUM (0.60) TDO2NPC1RAB9ATP53TSHR
SCHEMBL5164717 0.69 SOS1 (0.45) TDO2NPC1RAB9ATP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379514-A1 NEW PROCESS FOR THE PREPARATION OF 1- [5- (3-CHLORO-PHENYL) - ISOOXAZOL-3-YL]-ETHANONE AND (R) -1- [5- (3-CHLORO-PHENYL) - ISOOXAZOL-3-YL]-ETHANOL AstraZeneca AB (SE) 2011-10-26 EP claimed
WO-2010071558-A1 NEW PROCESS FOR THE PREPARATION OF 1- [5- (3-CHLORO-PHENYL) - ISOOXAZOL-3-YL] -ETHANONE AND (R) -1- [5- (3-CHLORO-PHENYL) - ISOOXAZOL-3-YL] -ETHANOL ASTRAZENECA AB (SE) 2010-06-24 WO claimed
EP-2379514-A4 NEW PROCESS FOR THE PREPARATION OF 1- [5- (3-CHLORO-PHENYL) - ISOOXAZOL-3-YL]-ETHANONE AND (R) -1- [5- (3-CHLORO-PHENYL) - ISOOXAZOL-3-YL]-ETHANOL ASTRAZENECA AB (SE) 2012-06-13 EP disclosed
EP-2379514-A1 NEW PROCESS FOR THE PREPARATION OF 1- [5- (3-CHLORO-PHENYL) - ISOOXAZOL-3-YL]-ETHANONE AND (R) -1- [5- (3-CHLORO-PHENYL) - ISOOXAZOL-3-YL]-ETHANOL AstraZeneca AB (SE) 2011-10-26 EP disclosed
EP-1536790-A2 OXADIAZOLES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 AstraZeneca AB (SE) 2005-06-08 EP disclosed
WO-2004014370-A2 OXADIAZOLES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 ASTRAZENECA AB (SE) 2004-02-19 WO disclosed